Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Brandt

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The American Surgeon|July 1, 1997
Pancreatic trauma: a ten-year multi-institutional experienceR Akhrass, M B Yaffe, C P Brandt, et al.
The Journal of Burn Care & Rehabilitation|June 14, 2001
Management of an inpatient-outpatient clinic an eight-year reviewL C Yurko, T L Coffee, J Fusilero, et al.
American Journal of Surgery|August 1, 1996
Is deep vein thrombosis surveillance warranted in high-risk trauma patients?J J Piotrowski, J J Alexander, C P Brandt, et al.
Cellular Immunology|October 15, 1984
Selective inhibition of natural killer activity by the monoclonal antibodies OKT10 and VEP10 at the single cell levelM G Golightly, H S Koren, W W Travis, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The American Surgeon|July 1, 1997
Pancreatic trauma: a ten-year multi-institutional experienceR Akhrass, M B Yaffe, C P Brandt, et al.
The Journal of Burn Care & Rehabilitation|June 14, 2001
Management of an inpatient-outpatient clinic an eight-year reviewL C Yurko, T L Coffee, J Fusilero, et al.
American Journal of Surgery|August 1, 1996
Is deep vein thrombosis surveillance warranted in high-risk trauma patients?J J Piotrowski, J J Alexander, C P Brandt, et al.
Cellular Immunology|October 15, 1984
Selective inhibition of natural killer activity by the monoclonal antibodies OKT10 and VEP10 at the single cell levelM G Golightly, H S Koren, W W Travis, et al.
Pageof 3